Howard Capital Management Group LLC Cuts Holdings in iShares Biotechnology ETF $IBB

Howard Capital Management Group LLC lowered its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.1% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 38,827 shares of the financial services provider’s stock after selling 840 shares during the period. Howard Capital Management Group LLC owned about 0.09% of iShares Biotechnology ETF worth $4,912,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Ramirez Asset Management Inc. purchased a new stake in shares of iShares Biotechnology ETF during the first quarter worth about $26,000. Financial Gravity Asset Management Inc. purchased a new stake in shares of iShares Biotechnology ETF during the first quarter worth about $30,000. Woodside Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF during the first quarter worth about $31,000. CX Institutional purchased a new stake in shares of iShares Biotechnology ETF during the first quarter worth about $32,000. Finally, Garde Capital Inc. purchased a new stake in shares of iShares Biotechnology ETF during the first quarter worth about $36,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

IBB stock opened at $140.96 on Friday. The firm has a 50-day simple moving average of $137.83 and a 200-day simple moving average of $129.56. iShares Biotechnology ETF has a 52 week low of $107.43 and a 52 week high of $150.04.

iShares Biotechnology ETF Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were paid a dividend of $0.0828 per share. This represents a $0.33 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend was Tuesday, September 16th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.